Mosaic TX
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Wellcome Genome Campus, Cambridge, Cambr...Website
www.mosaic-tx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Mosaic TX
Mosaic Therapeutics is an oncology therapeutics company focused on discovering and developing targeted drug combinations in novel biomarker-defined settings to address substantial unmet needs in cancer treatment. The company leverages a unique combination of experimental biology and computational platforms to redefine patient outcomes and accelerate the development of effective therapies. With a world-class team of scientists and clinicians, Mosaic aims to provide more effective and less toxic therapies through molecularly-guided stratification of precision medicines. Their partnerships, including a strong alliance with the Wellcome Sanger Institute, enhance their capabilities in improving cancer patient outcomes.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mosaic TX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Mosaic TX
Check out if Mosaic TX is spiking on competitors!
Mosaic TX, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Mosaic TX has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Mosaic TX launches new products
Earning: See what the market has to say on Mosaic TX recently announced quarterly report
Click to see if Mosaic TX had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Mosaic TX has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Mosaic TX as Masked Content
Find more new buyers
Compare Similar Companies to Mosaic TX
Compare insights from companies similar to Mosaic TX, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mosaic TX
<$5M
1-10
Private
$28M
2020
N/A
Company Profile Activity
Activity Insights
Mosaic TX is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mosaic TX is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mosaic TX.
Mosaic TX financials insights
Gather financial insights about Mosaic TX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$28M
Mosaic TX Tech Stack
A closer look at the technologies used by Mosaic TX
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Mosaic TX has announced that Brian Gladsden has joined the organization as Chief Executive Officer. Previously, Gladsden served as Senior Vice President for Novartis Oncology.
Funding
Mosaic TX News & Media
Mosaic Therapeutics In-Licenses Two Clinical-Stage Oncology Programs From Astex Pharmaceuticals for Development as Proprietary Combination Therapies
CAMBRIDGE, England--(BUSINESS WIRE)--Mosaic Therapeutics, Ltd (‘Mosaic’, or ‘the Company’) a targeted oncology therapeutics company dedicated to resolving cancer’s complexity with new combination therapies for patients, today announces the in-licensing of two clinical-stage oncology programs from Astex Pharmaceuticals (‘Astex’), a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd. Mosaic has identified proprietary combinations incorporating the licensed products and their targets and thiMosaic Therapeutics Closes $28m Series A Funding and Appoints Brian Gladsden as CEO
CAMBRIDGE, England--(BUSINESS WIRE)--Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients, today announced the close of its $28 million series A funding round. The Company also announces the appointment of former Novartis Oncology SVP Brian Gladsden as CEO. The investment in this round was raised from Syncona Investment Management, Ltd, and Cambridge Innovation Capital. The Series
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mosaic TX
Sign Up For FreeTo access detailed company insights
Mosaic Therapeutics is an oncology therapeutics company focused on discovering and developing targeted drug combinations in novel biomarker-defined settings to address substantial unmet needs in cancer treatment. The company leverages a unique combination of experimental biology and computational platforms to redefine patient outcomes and accelerat... Read More
